Drug Type Small molecule drug |
Synonyms AN 018, AN018 |
Target |
Action agonists |
Mechanism SIRT3 agonists(NAD-dependent protein deacetylase sirtuin-3, mitochondrial agonists) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Dementia | Preclinical | United States | 01 Dec 2025 | |
| Neurocognitive Disorders | Preclinical | United States | 01 Dec 2025 | |
| Parkinson Disease | Preclinical | United States | 01 Dec 2025 |





